Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
Dow
Colorcon
Mallinckrodt
McKinsey
Johnson and Johnson

Last Updated: August 14, 2022

ULTANE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Ultane patents expire, and when can generic versions of Ultane launch?

Ultane is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in ULTANE is sevoflurane. There are five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the sevoflurane profile page.

Drug patent expirations by year for ULTANE
Drug Prices for ULTANE

See drug prices for ULTANE

Recent Clinical Trials for ULTANE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alberta Children's HospitalPhase 2
Emory UniversityPhase 4
Medical College of WisconsinPhase 4

See all ULTANE clinical trials

Pharmacology for ULTANE
Drug Class General Anesthetic
Physiological EffectGeneral Anesthesia
Anatomical Therapeutic Chemical (ATC) Classes for ULTANE

US Patents and Regulatory Information for ULTANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 AN RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ULTANE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 See Plans and Pricing See Plans and Pricing
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 See Plans and Pricing See Plans and Pricing
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 See Plans and Pricing See Plans and Pricing
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

EU/EMA Drug Approvals for ULTANE

Company Drugname Inn Product Number / Indication Status Generic Biosimilar Orphan Marketing Authorisation Marketing Refusal
Chanelle Pharmaceuticals Manufacturing Limited Sevohale (previously known as Sevocalm) sevoflurane EMEA/V/C/004199
For the induction and maintenance of anaesthesia.
Authorised yes no no 2016-06-21
Zoetis Belgium SA SevoFlo sevoflurane EMEA/V/C/000072
For the induction and maintenance of anaesthesia in dogs and cats.
Authorised no no no 2002-12-11
>Company >Drugname >Inn >Product Number / Indication >Status >Generic >Biosimilar >Orphan >Marketing Authorisation >Marketing Refusal

International Patents for ULTANE

See the table below for patents covering ULTANE around the world.

Country Patent Number Title Estimated Expiration
Poland 193865 See Plans and Pricing
Norway 993606 See Plans and Pricing
Spain 2256104 See Plans and Pricing
Japan 2006143742 FLUOROETHER COMPOSITIONS AND METHODS FOR INHIBITING THEIR DEGRADATION IN THE PRESENCE OF LEWIS ACID See Plans and Pricing
China 1321958 See Plans and Pricing
Japan 2001187729 FLUOROETHER COMPOSITION AND METHOD FOR SUPPRESSING DEGRADATION OF THE SAME IN THE PRESENCE OF LEWIS ACID See Plans and Pricing
Australia 2110999 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Merck
McKesson
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.